Total cerebral small vessel score associated with Hoehn and Yahr stages in Parkinson’s disease
Objective: To evaluate the total cerebral small vessel disease (CSVD) score in patients with Parkinson’s disease at different stages and its related factors. Background: Parkinson’s…Peripheral immune profile and neutrophil-to-lymphocyte ratio in Parkinson’s disease
Objective: The present study aimed to determine whether a different peripheral immune profile and neutrophil-to-lymphocyte ratio were present in Parkinson’s disease (PD) patients compared with…Gut microbiota in patients with Parkinson’s disease (PD) predicts disease progression better than clinical features
Objective: To compare machine-learning models to predict the progression of PD using gut microbiota and clinical features. Background: A total of 21 studies including ours…Motor Function Test Protocol for Parkinsonian Triad in Rodent Model of Parkinson’s Disease
Objective: To review motor deficits protocols and create a set of behavioural protocols that critically address the parkinsonian triad's quantification in Parkinson's disease models. Background:…Cerebrospinal fluid levels of oxidative stress measured using diacron-reactive oxygen metabolites and biological antioxidant potential in patients with Parkinson’s disease and progressive supranuclear palsy
Objective: We aimed to evaluate cerebrospinal fluid (CSF) levels of oxidative stress (OS) and antioxidant potential using diacron-reactive oxygen metabolites (d-ROMs) and biological antioxidant potential…Soluble urokinase-type plasminogen activator receptor (SuPAR) in patients with Parkinson’s disease
Objective: The objective of this study was to assess if soluble urokinase-type plasminogen activator receptor (SuPAR) is elevated in patients with Parkinson's disease (PD). Background:…Do Parkinson’s disease medications have an effect on gut microbiome? A case-control study
Objective: To investigate the difference in the gut microbiota between drug-naïve and medicated PD patients and focus on the association between gut microbiota and anti-PD medications. Background:…Effect of COVID-19 stressors on mental health and quality of life in Parkinson’s disease
Objective: To investigate subgroup differences in the effect of COVID-19 stressors on mental health and quality of life in people with Parkinson’s disease. Background: In…Predictors of antidepressant and benzodiazepine treatment in Parkinson’s disease
Objective: To assess the prevalence of antidepressant and benzodiazepine (BDZ) treatment in Parkinson’s disease (PD), to analyze treatment with respect to altered mood indication, and…CAN DANCE AS A COMPLEMENTARY THERAPY REDUCE THE OCCURRENCE OF DEPRESSION AND APATHY IN PEOPLE WITH PARKINSON’S DISEASE?
Objective: To investigate the effects of dance as complementary therapy over the presentation of depression and apathy in people with Parkinson’s Disease (PD). Background: Depression…
- « Previous Page
- 1
- …
- 796
- 797
- 798
- 799
- 800
- …
- 1734
- Next Page »